Results
responsible for the majority of the enhancer blocking activity of the core. While deletion of FI slightly increased the enhancer blocking effect, deletion of FII and FIII We showed in earlier studies that a 1.2 kb DNA element at the 5Ј end of the chicken ␤-globin locus, correspondsignificantly reduced enhancer blocking activity ( Figure  1C ). Deletions of FIV and FV were essentially neutral. ing to a constitutive DNase I-hypersensitive site (5ЈHS4), functions as an insulator in an enhancer blocking assay.
Insertion of an increasing number of copies of the FII/ III fragment between the enhancer and the promoter This assay tests the ability of a sequence to prevent activation of a gene for neomycin resistance by a strong resulted in a stepwise increase in blocking activity; an increase was also observed for the 1.2 kb insulator and enhancer when the construct is stably transformed into an erythroleukemia cell line (Chung et al., 1993) . The the core ( Figure 1D ). Taken together these results show that the FII/III fragment is the functional enhancerinsulator effect is manifested by a marked reduction in the number of colonies resistant to G418 only when blocking region of the core. Further analysis of the FII/FIII fragment showed that the globin insulator is placed between enhancer and promoter. By this same assay, we showed that a large removal of the "spacer" sequence between FII and FIII resulted in even stronger blocking activity ( Figure 2A) . part of the insulator activity is contained in a 250 bp GC-rich "core" fragment at the 5Ј end of the 1.2 kb In fact, by removing sequences adjacent to FII, we obtained a 42 bp sequence spanning FII that alone poselement (Chung et al., 1997) . HS4 maps precisely within this core region, consistent with its significance in vivo sessed a blocking activity nearly equal to that of the full 1.2 kb insulator. Consistent with its functional impor-( Figure 1A) . tance, we note that the position of FII is coincident with that of HS4 in nuclei ( Figure 1A) . Importantly, enhancer Fine Mapping of Directional Enhancer-Blocking Sequences blocking by FII displays the same position-dependence as that observed for the full 1.2 kb insulator ( Figure 2B ; DNase I footprinting of the core revealed five protected regions (FI to FV, illustrated in Figure 1A ; Chung et al., Chung et al., 1997) . When placed either upstream of the enhancer or downstream of the promoter, FII has 1997). We chose to focus on this fragment to identify an insulator protein-binding site. We divided the core essentially no effect on colony number in our assay. Thus, in order to affect expression, FII must be located into separate segments and carried out enhancer blocking assays with each fragment. Splitting the core between between the enhancer and the promoter. FII and FIII generated two fragments (FI/FII and FIII/IV/ V) each of which had some enhancer blocking activity.
Identification of a Candidate Enhancer-Blocking Protein However, a fragment containing only FII and FIII had greater activity than the entire core (FII/III, Figure 1B) .
Since the FII fragment had the strongest activity, we focused our attention on identifying proteins that bound Deletion analyses confirmed that FII and FIII were each of these proteins for this sequence. A deletion of 4 base pairs within the region that overlaps both the ␣2-and the Su[Hw]-binding sites had no effect on the blocking activity of the FII/III fragment ( Figure 2D ). Furthermore, a 100 bp fragment, derived from the Drosophila gypsy element, that contains three canonical Su[Hw]-binding sites, had no activity in our assay. We conclude that neither the Su[Hw] nor the ␣2 site can account for the activity of FII.
Likewise, in the context of FII, mutation of the Sp1 consensus had no effect on blocking activity; in fact, mutation of each of the three potential Sp1-binding sites in FII/III resulted in substantially increased activity (Figure 2C ). Sp1 may act as an inhibitor of enhancer blocking in our assay. This may also explain the inhibitory effect of the "spacer" sequence between FII and FIII noted above.
To determine which sequences within FII are responsible for its activity we made multiple transversions (C→A and G→T) across the 5Ј, middle (M), and 3Ј regions of the fragment ( Figure 3A ). All of these reduced the activity of FII, but changes at the 3Ј end of the fragment (x3Ј) caused a complete loss of enhancer blocking activity. Likewise, deletion of 10 bp from both ends (⌬F) or a reversal of the sequence 5Ј→3Ј (rev) resulted in substantial losses in activity.
Armed with this information, we searched for a protein that bound to FII with a competition profile that matched the sequence specificity observed in the enhancer blocking assay. To do this, we made nuclear extracts from the human erythroleukemic cell line K562 (the cell line in which the enhancer blocking assay is performed) and from adult chicken red blood cells (since this insulator is a chicken element). Identical patterns were obtained with these two extracts in a gel mobility-shift assay ( Figure 3B ). In each case two major complexes were observed when the extract was incubated with a in the gel-shift assay and was also in good agreement whether any of these homologies could account for the with the enhancer blocking data ( Figure 3C and 4A). We blocking activity of FII, we introduced mutations that were predicted to reduce dramatically the affinity of purified this protein from chicken red blood cell nuclear spanning one repeat unit of RO binds specifically, albeit weakly, to CTCF in vitro ( Figure 7A ). In our in vivo assay, Consistent with this identification, in vitro-translated CTCF binds to FII with a sequence specificity identical the full-length RO element conferred considerable enhancer blocking activity, and a single copy of the 100 to that observed in our gel-mobility shift and enhancer blocking assays ( Figure 5 ). As is expected, this protein bp repeat from this element had weak enhancer blocking activity on its own ( Figure 7B ). also binds to other previously characterized CTCF sites ( Figure 5, lanes 9-11) , and these sites also act as enAnother vertebrate insulator, BEAD-1, is a 1.6 kb enhancer-blocking element derived from the human T cell hancer blockers in our assay ( Figure 5 ). Alignment of these CTCF sites with FII reveals a conserved region receptor ␣/␦ locus (Zhong and Krangel, 1997). Bestfit alignment of this element with various CTCF sites that has been shown to be critical for binding of CTCF to these other sites (Filippova et al., 1996 ; Burcin et al., revealed a good match between FII and a sequence roughly at the center of this element (BEAD-A in Figure  1997 ; Vostrov and Quitschke, 1997). We note that it was mutation of this conserved 3Ј sequence that completely 6C). In fact, a DNA fragment containing this region also bound specifically to purified chicken CTCF ( Figure 7A ). abrogated CTCF binding and enhancer blocking in our assays (see x3Ј in Figure 3 and alignments in 6A).
Consistent with these observations, both full-length 
BEAD-1 and the CTCF-binding BEAD-A element defined
However, mutations of the 3Ј end of this site did abolish enhancer blocking. here were effective enhancer-blocking elements in our assay ( Figure 7B ). Furthermore, deletion of the BEAD-A When FII was used as a probe in gel retardation experiments with crude extracts, two major complexes sequence from BEAD-1 largely eliminated the activity of the larger element.
were observed. One of these was attributable to Sp1. The other had properties implicating it in insulating activity: it was competed by any DNA that was also active Discussion in the enhancer blocking assay, but not by any of the inactive mutated sequences. Similar gel shift patterns A major defining property of insulators is their ability were obtained with extracts from chicken erythrocyte to interfere with enhancer-promoter interaction when nuclei and the human erythroleukemia line K562, in placed between them. Our laboratory previously has which the enhancer blocking assays were carried out. shown that a 1.2 kb element at the 5Ј end of the chicken We used this result to purify the protein responsible for ␤-globin locus has such enhancer blocking activity. Here this complex and found that it was identical to a known we identify a small DNA sequence motif within this insuprotein, CTCF. Consistent with this, in vitro-translated lator that is sufficient to account for most of its ability CTCF bound FII with sequence specificity identical to to block enhancers. A 42 bp fragment containing the the original complex. Furthermore, the original complex motif was able to suppress enhancer activity in a direcwas supershifted with an antibody against CTCF. tional manner about as well as the full 1.2 kb element CTCF is an 82 kDa protein with 11 zinc fingers (Filipfrom which it was derived. Although the fragment conpova et al., 1996) and is characterized by an unusually tains binding sites for Sp1 and the yeast ␣2 repressor, mutating these sites had no effect on blocking activity.
extensive DNase I footprint (51 bp) when bound to its We find that the enhancer blocking activity of the 5Ј ␤-globin insulator is dependent upon CTCF, and that similar sequences are present in the two other vertebrate insulators. The first of these is the BEAD-1 element found in the human T cell receptor (TCR) ␣/␦ locus (Zhong and Krangel, 1997). BEAD-1, which has strong directional enhancer blocking properties, is located between TCR␦ gene segments and TCR␣ joining gene segments. It has been proposed that BEAD-1 prevents a ␦-specific enhancer from acting on the ␣ genes early in T cell development. We have shown here that BEAD-1 contains a CTCF-binding site and that this site is responsible for a large portion of the observed enhancer blocking activity. We have also examined the enhancer blocking activity of an element that derives from the 5Ј-boundary of the chicken lysozyme gene (Stief et al., 1989). Consistent with the findings of Stief et al., we found that this element conferred considerable enhancer blocking activity in our assay and that this element contains (at least) two bona fide binding sites for CTCF, both of which are independently capable of enhancer blocking in our assays (data not shown). these elements. In our assay, this element was effective in enhancer blocking, whereas analogous constructions blocking capacity of this element was revealed. This failed to reveal the enhancer blocking capacity of this activity is equal to that observed with the entire 1.2 kb element in Xenopus oocytes. These discrepancies may insulator (Chung et al., 1993) . Our conclusions are further be explained by differences in the enhancer and prosupported by the observation that, in vivo, the enhancer moter functions in these systems or they may reflect blocking activity of various mutated FII fragments accuspecies or cell type-specific differences in the contriburately parallels the capacity of these fragments to bind tion of CTCF, or other factors, to the enhancer blocking CTCF in vitro. Finally, in every case we examined, bindcapacity of RO. To date, a Xenopus homolog of CTCF ing sites for CTCF were capable of directional enhancer has not been identified. However, given the fact that blocking in vivo. Taken supplemented with 0.25% nonfat dry milk, 5 g/ml poly-dI/dC, and 3 pmol of labeled probe in a final volume of 20 ml, washed three ACGAGACCCAGCTCCCTGCTGGCGGAAGGGCGCGCCT. All FII mutants were identical to FII except for those bases indicated in times for 10 min in the same buffer without probe and exposed to film. In the example shown in Figure 4A , samples from an early pilot lowercase in Figure 3C . For use in the enhancer blocking assay, complementary single-stranded oligonucleotides were purified by purification were loaded as follows: fractions of a large S sepharose, second small S sepharose, and subsequent Q sepharose column denaturing PAGE, annealed, and subcloned into pNI. The FII site was also generated with NdeI sites at its ends for cloning upstream were loaded from left to right in each of the panels shown and probed as indicated in the figure legend. of the enhancer in pNI to generate FII-UP. To generate FII-DOWN, FII was digested out of pNI-FII, the ends were flushed with Klenow, and XbaI linkers (New England Biolabs) were added for cloning into Protein Purification and Translation the XbaI site of pNI.
Nuclear extracts from K562 cells and whole chicken blood were prepared essentially as previously described (Evans et al., 1988) . For purification of the FII-binding protein, nuclei were prepared from Enhancer Blocking Assay 6 liters of whole chicken blood (Pelfreez Biologicals) and extracted Enhancer blocking assays were performed as previously described in buffer C: 20 mM HEPES (pH 7.9), 420 mM NaCl, 5 mM MgCl 2 , 0.2 (Chung et al., 1993, 1997) . Briefly, 20 g of each construct was mM EDTA, and 1 mM DTT. The resulting extract was diluted to 150 linearized by SalI digestion, phenol-chloroform extracted, ethanol mM NaCl/20% glycerol in the same buffer and fractionated on a precipitated, and quantified by UV absorption. Twenty nanograms 500 ml SP sepharose column (Pharmacia) using a 0.15-1 M NaCl of each DNA was then electroporated into 1 ϫ 10 7 K562 cells and, linear gradient. Active fractions were pooled, diluted to ‫051ف‬ mM after 24 hr of recovery, cells were plated in soft agar with geneticin NaCl, and fractionated on a 25 ml CM sepharose column with a at 750 g/ml. Colonies were counted after 3 weeks of selection and 0.15-1 M NaCl gradient. These fractions were pooled and loaded the colony number was normalized to that obtained with pNI or onto a 2.6/60 cm Sephacryl S-300 gel filtration column (Pharmacia) pJC3-4 (Chung et al., 1993) . preequilibrated with 20 mM HEPES (pH 7.9), 150 mM NaCl, 5 mM MgCl 2 , 0.2 mM EDTA, and 1 mM DTT. Active fractions were pooled, DNase I-Hypersensitive Site Analysis dialyzed into 10 mM potassium phosphate (pH 8.0), 150 mM NaCl, Nuclei were isolated from adult chicken red blood cells essentially 5 mM MgCl 2 , 1 mM DTT, 20% glycerol, and loaded onto a 25 ml as described previously (Bresnick and Felsenfeld, 1994) except that Macro-Prep ceramic hydroxyapatite column (Bio-Rad). This column 0.2 mM EGTA was included in all buffers. After incubation of the was eluted with a 10-800 mM phosphate gradient at pH 8.0. nuclei with varying concentrations of DNase I for 5 min at room Throughout the isolation all buffers were supplemented with 1 mM temperature, the reaction was terminated by the addition of SDS PMSF, 0.7 g/ml pepstatin, and 0.5 g/ml leupeptin and maintained and genomic DNA was purified. To map precisely the position of at 4ЊC. Fractions pooled from the gel filtration, and all subsequent HS4, DNase I digested and undigested genomic DNAs (10 g) were buffers, were supplemented with 40 g/ml bestatin and 200 g/ further digested with StyI to generate an ‫1ف‬ kb parent fragment ml AEBSF. For peptide sequencing, 1 ml of a final active fraction that spanned the insulator core. This DNA was then digested with (representing ‫01/1ف‬th of our final yield and ‫5ف‬ g of purified ‫041ف‬ the enzymes indicated in Figure 1A . Digested DNA was resolved on kDa protein) was TCA precipitated, resolved on a 7% Tris-acetate a 1.3% agarose gel and subjected to Southern blotting by standard SDS-PAGE (Novex), transferred to PVDF, stained with amido black, techniques using a 503 bp StyI-SacI fragment of p501 (Reitman and and internal protein sequence was obtained at the Rockefeller UniFelsenfeld, 1990) as a probe.
versity Protein/DNA Technology Center by in situ digestion with endoproteinase Lys-C followed by HPLC purification of individual DNA Binding Assays peptides and Edman sequence determination of each peptide. In All DNA binding assays were carried out in a binding buffer comvitro-translated human CTCF was obtained using the plasmid posed of 20 mM HEPES (pH 7.9), 150 mM KCl, 5 mM MgCl 2 , 1 mM p4B7.1 (obtained from V. Lobanenkov) as a template for in vitro DTT. For gel mobility shift assays, DNA binding was carried out at transcription by T7 polymerase according to the manufacturer's room temperature for 30 min in binding buffer plus 5% glycerol, instructions (Ambion, "Message Machine"), followed by in vitro 20-40 fmol of end-labeled probe, poly-dI/dC at 50-100 g/ml, 0.5% translation of the resulting RNA in a nuclease-treated rabbit reticuloTriton X-100, and 1-5 l of protein in 20 l. Probes were oligonucleocyte system (Promega). tide duplexes identical to those used for sub-cloning into the enhancer-blocking vector. The RO and BEAD sites, trimmed down for
